NDATF.US nDatalyze Corp

Healthcare Health Care Technology USA Stocks
0.1472 USD
Close of Nov 15, 2026
0.0109 0.0800
Market cap
USD 6.08M
P/E
-
P/B
14.24x
ROE
-88.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Aug 2026.

Is NDATF.US undervalued?

Graham number

The Graham number of nDatalyze Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

nDatalyze Corp fundamental analysis

No fundamental analysis for nDatalyze Corp yet.

nDatalyze Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About nDatalyze Corp

nDatalyze Corp. provides technologically based solutions related to applying machine learning to a records database to predict probable mental health conditions. The company provides Sigmund, a machine-learning-based online mental health application for the mental health system, such as misdiagnosis and mis prescription. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze Corp. in October 2021. nDatalyze Corp. was incorporated in 2018 and is…

Full company profile